Depressive-like phenotype induced by AAV-mediated overexpression of human α-synuclein in midbrain dopaminergic neurons
Parkinson's disease (PD) is a neurodegenerative disorder characterized by a progressive loss of nigral dopaminergic neurons and by the presence of aggregates containing α-synuclein called Lewy bodies. Viral vector-induced overexpression of α-synuclein in dopaminergic neurons represents a model...
Gespeichert in:
Veröffentlicht in: | Experimental neurology 2015-11, Vol.273, p.243-252 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 252 |
---|---|
container_issue | |
container_start_page | 243 |
container_title | Experimental neurology |
container_volume | 273 |
creator | Caudal, D. Alvarsson, A. Björklund, A. Svenningsson, P. |
description | Parkinson's disease (PD) is a neurodegenerative disorder characterized by a progressive loss of nigral dopaminergic neurons and by the presence of aggregates containing α-synuclein called Lewy bodies. Viral vector-induced overexpression of α-synuclein in dopaminergic neurons represents a model of PD which recapitulates disease progression better than commonly used neurotoxin models. Previous studies using this model have reported motor and cognitive impairments, whereas depression, mood and anxiety phenotypes are less described. To investigate these psychiatric phenotypes, Sprague–Dawley rats received bilateral injections of a recombinant adeno-associated virus (AAV) vector expressing human α-synuclein or GFP into the substantia nigra pars compacta. Behavior was assessed at two timepoints: 3 and 8weeks post-injection. We report that nigral α-synuclein overexpression led to a pronounced nigral dopaminergic cell loss accompanied by a smaller cell loss in the ventral tegmental area, and to a decreased striatal density of dopaminergic fibers. The AAV-α-synuclein group exhibited modest, but significant motor impairments 8weeks after vector administration. The AAV-α-synuclein group displayed depressive-like behavior in the forced swim test after 3weeks, and reduced sucrose preference at week 8. At both timepoints, overexpression of α-synuclein was linked to a hyperactive hypothalamic–pituitary–adrenal (HPA) axis regulation of corticosterone. The depressive-like phenotype was also correlated with decreased nigral brain-derived neurotrophic factor and spinophilin levels, and with decreased striatal levels of the activity-regulated cytoskeleton-associated protein. This study demonstrates that AAV-mediated α-synuclein overexpression in dopamine neurons is not only useful to model motor impairments of PD, but also depression. This study also provides evidence that depression in experimental Parkinsonism is correlated to dysregulation of the HPA axis and to alterations in proteins involved in synaptic plasticity.
•α-Synuclein overexpression in midbrain dopaminergic neurons induces a depressive-like phenotype•HPA axis hyperactivation is induced by α-synuclein overexpression in midbrain dopaminergic neurons•α-Synuclein overexpression is linked to decreased nigral BDNF and spinophilin levels, and decreased striatal Arc levels. |
doi_str_mv | 10.1016/j.expneurol.2015.09.002 |
format | Article |
fullrecord | <record><control><sourceid>proquest_swepu</sourceid><recordid>TN_cdi_swepub_primary_oai_swepub_ki_se_510760</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0014488615300844</els_id><sourcerecordid>1733196331</sourcerecordid><originalsourceid>FETCH-LOGICAL-c478t-7ff5294b66f1da16fc6d9403e1eb9365a3973ee3a630322a0461e28ec6ee55353</originalsourceid><addsrcrecordid>eNqFkc2O0zAUhSMEYsrAK0CWbBKuf-LUy2r4lSqxAbaWY98w7iR2sJMOfSxehGfCnZbuEAvb11fn3GP5K4pXBGoCRLzZ1fhz8rjEMNQUSFODrAHoo2JFQEJFOYPHxQqA8Iqv1-KqeJbSDgAkp-3T4ooKJhiXzaq4f4tTxJTcHqvB3WE53aIP82HC0nm7GLRldyg3m2_ViNbpOd_DHmNOf3AFX4a-vF1G7cvfv6p08IsZ0PlsLkdnu6hzYcOkR-cxfnemfHi0T8-LJ70eEr44n9fF1_fvvtx8rLafP3y62Wwrw9v1XLV931DJOyF6YjURvRFWcmBIsJNMNJrJliEyLRgwSjVwQZCu0QjEpmENuy6q09x0j9PSqSm6UceDCtqpc-suV6gaAq2ArN_-Uz8sU15dXkcDkbRFY3tFDRDFLZOqA26UaQ3NLdA9Z3nc69O4KYYfC6ZZjS4ZHAbtMSxJkZYxIkXesrQ9SU0MKUXsL9kE1BG62qkLdHWErkCqDD07X55Dli5Tuvj-Us6CzUmA-af3DqNKxqHPcF1EMysb3H9D_gABN8XC</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1733196331</pqid></control><display><type>article</type><title>Depressive-like phenotype induced by AAV-mediated overexpression of human α-synuclein in midbrain dopaminergic neurons</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Caudal, D. ; Alvarsson, A. ; Björklund, A. ; Svenningsson, P.</creator><creatorcontrib>Caudal, D. ; Alvarsson, A. ; Björklund, A. ; Svenningsson, P.</creatorcontrib><description>Parkinson's disease (PD) is a neurodegenerative disorder characterized by a progressive loss of nigral dopaminergic neurons and by the presence of aggregates containing α-synuclein called Lewy bodies. Viral vector-induced overexpression of α-synuclein in dopaminergic neurons represents a model of PD which recapitulates disease progression better than commonly used neurotoxin models. Previous studies using this model have reported motor and cognitive impairments, whereas depression, mood and anxiety phenotypes are less described. To investigate these psychiatric phenotypes, Sprague–Dawley rats received bilateral injections of a recombinant adeno-associated virus (AAV) vector expressing human α-synuclein or GFP into the substantia nigra pars compacta. Behavior was assessed at two timepoints: 3 and 8weeks post-injection. We report that nigral α-synuclein overexpression led to a pronounced nigral dopaminergic cell loss accompanied by a smaller cell loss in the ventral tegmental area, and to a decreased striatal density of dopaminergic fibers. The AAV-α-synuclein group exhibited modest, but significant motor impairments 8weeks after vector administration. The AAV-α-synuclein group displayed depressive-like behavior in the forced swim test after 3weeks, and reduced sucrose preference at week 8. At both timepoints, overexpression of α-synuclein was linked to a hyperactive hypothalamic–pituitary–adrenal (HPA) axis regulation of corticosterone. The depressive-like phenotype was also correlated with decreased nigral brain-derived neurotrophic factor and spinophilin levels, and with decreased striatal levels of the activity-regulated cytoskeleton-associated protein. This study demonstrates that AAV-mediated α-synuclein overexpression in dopamine neurons is not only useful to model motor impairments of PD, but also depression. This study also provides evidence that depression in experimental Parkinsonism is correlated to dysregulation of the HPA axis and to alterations in proteins involved in synaptic plasticity.
•α-Synuclein overexpression in midbrain dopaminergic neurons induces a depressive-like phenotype•HPA axis hyperactivation is induced by α-synuclein overexpression in midbrain dopaminergic neurons•α-Synuclein overexpression is linked to decreased nigral BDNF and spinophilin levels, and decreased striatal Arc levels.</description><identifier>ISSN: 0014-4886</identifier><identifier>EISSN: 1090-2430</identifier><identifier>DOI: 10.1016/j.expneurol.2015.09.002</identifier><identifier>PMID: 26363495</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Adrenocorticotropic Hormone - blood ; Alpha-synuclein ; alpha-Synuclein - genetics ; alpha-Synuclein - metabolism ; Animals ; Anxiety ; Basic Medicine ; Corticosterone ; Corticosterone - blood ; Dependovirus - genetics ; Depression ; Depression - blood ; Depression - etiology ; Depression - genetics ; Depression - pathology ; Disease Models, Animal ; Dopaminergic Neurons - pathology ; Female ; Food Preferences - psychology ; Gene Expression Regulation - genetics ; Humans ; Longitudinal Studies ; Maze Learning - physiology ; Medical and Health Sciences ; Medicin och hälsovetenskap ; Medicinska och farmaceutiska grundvetenskaper ; Mesencephalon - pathology ; Neurosciences ; Neurovetenskaper ; Parkinson disease ; Phenotype ; Psychomotor Performance - physiology ; Rats ; Rats, Sprague-Dawley ; Rats, Transgenic ; Stress, Psychological - complications ; Swimming - psychology ; Time Factors</subject><ispartof>Experimental neurology, 2015-11, Vol.273, p.243-252</ispartof><rights>2015 Elsevier Inc.</rights><rights>Copyright © 2015 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c478t-7ff5294b66f1da16fc6d9403e1eb9365a3973ee3a630322a0461e28ec6ee55353</citedby><cites>FETCH-LOGICAL-c478t-7ff5294b66f1da16fc6d9403e1eb9365a3973ee3a630322a0461e28ec6ee55353</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.expneurol.2015.09.002$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,776,780,881,3536,27903,27904,45974</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26363495$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://lup.lub.lu.se/record/8042481$$DView record from Swedish Publication Index$$Hfree_for_read</backlink><backlink>$$Uhttp://kipublications.ki.se/Default.aspx?queryparsed=id:132462383$$DView record from Swedish Publication Index$$Hfree_for_read</backlink></links><search><creatorcontrib>Caudal, D.</creatorcontrib><creatorcontrib>Alvarsson, A.</creatorcontrib><creatorcontrib>Björklund, A.</creatorcontrib><creatorcontrib>Svenningsson, P.</creatorcontrib><title>Depressive-like phenotype induced by AAV-mediated overexpression of human α-synuclein in midbrain dopaminergic neurons</title><title>Experimental neurology</title><addtitle>Exp Neurol</addtitle><description>Parkinson's disease (PD) is a neurodegenerative disorder characterized by a progressive loss of nigral dopaminergic neurons and by the presence of aggregates containing α-synuclein called Lewy bodies. Viral vector-induced overexpression of α-synuclein in dopaminergic neurons represents a model of PD which recapitulates disease progression better than commonly used neurotoxin models. Previous studies using this model have reported motor and cognitive impairments, whereas depression, mood and anxiety phenotypes are less described. To investigate these psychiatric phenotypes, Sprague–Dawley rats received bilateral injections of a recombinant adeno-associated virus (AAV) vector expressing human α-synuclein or GFP into the substantia nigra pars compacta. Behavior was assessed at two timepoints: 3 and 8weeks post-injection. We report that nigral α-synuclein overexpression led to a pronounced nigral dopaminergic cell loss accompanied by a smaller cell loss in the ventral tegmental area, and to a decreased striatal density of dopaminergic fibers. The AAV-α-synuclein group exhibited modest, but significant motor impairments 8weeks after vector administration. The AAV-α-synuclein group displayed depressive-like behavior in the forced swim test after 3weeks, and reduced sucrose preference at week 8. At both timepoints, overexpression of α-synuclein was linked to a hyperactive hypothalamic–pituitary–adrenal (HPA) axis regulation of corticosterone. The depressive-like phenotype was also correlated with decreased nigral brain-derived neurotrophic factor and spinophilin levels, and with decreased striatal levels of the activity-regulated cytoskeleton-associated protein. This study demonstrates that AAV-mediated α-synuclein overexpression in dopamine neurons is not only useful to model motor impairments of PD, but also depression. This study also provides evidence that depression in experimental Parkinsonism is correlated to dysregulation of the HPA axis and to alterations in proteins involved in synaptic plasticity.
•α-Synuclein overexpression in midbrain dopaminergic neurons induces a depressive-like phenotype•HPA axis hyperactivation is induced by α-synuclein overexpression in midbrain dopaminergic neurons•α-Synuclein overexpression is linked to decreased nigral BDNF and spinophilin levels, and decreased striatal Arc levels.</description><subject>Adrenocorticotropic Hormone - blood</subject><subject>Alpha-synuclein</subject><subject>alpha-Synuclein - genetics</subject><subject>alpha-Synuclein - metabolism</subject><subject>Animals</subject><subject>Anxiety</subject><subject>Basic Medicine</subject><subject>Corticosterone</subject><subject>Corticosterone - blood</subject><subject>Dependovirus - genetics</subject><subject>Depression</subject><subject>Depression - blood</subject><subject>Depression - etiology</subject><subject>Depression - genetics</subject><subject>Depression - pathology</subject><subject>Disease Models, Animal</subject><subject>Dopaminergic Neurons - pathology</subject><subject>Female</subject><subject>Food Preferences - psychology</subject><subject>Gene Expression Regulation - genetics</subject><subject>Humans</subject><subject>Longitudinal Studies</subject><subject>Maze Learning - physiology</subject><subject>Medical and Health Sciences</subject><subject>Medicin och hälsovetenskap</subject><subject>Medicinska och farmaceutiska grundvetenskaper</subject><subject>Mesencephalon - pathology</subject><subject>Neurosciences</subject><subject>Neurovetenskaper</subject><subject>Parkinson disease</subject><subject>Phenotype</subject><subject>Psychomotor Performance - physiology</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Rats, Transgenic</subject><subject>Stress, Psychological - complications</subject><subject>Swimming - psychology</subject><subject>Time Factors</subject><issn>0014-4886</issn><issn>1090-2430</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkc2O0zAUhSMEYsrAK0CWbBKuf-LUy2r4lSqxAbaWY98w7iR2sJMOfSxehGfCnZbuEAvb11fn3GP5K4pXBGoCRLzZ1fhz8rjEMNQUSFODrAHoo2JFQEJFOYPHxQqA8Iqv1-KqeJbSDgAkp-3T4ooKJhiXzaq4f4tTxJTcHqvB3WE53aIP82HC0nm7GLRldyg3m2_ViNbpOd_DHmNOf3AFX4a-vF1G7cvfv6p08IsZ0PlsLkdnu6hzYcOkR-cxfnemfHi0T8-LJ70eEr44n9fF1_fvvtx8rLafP3y62Wwrw9v1XLV931DJOyF6YjURvRFWcmBIsJNMNJrJliEyLRgwSjVwQZCu0QjEpmENuy6q09x0j9PSqSm6UceDCtqpc-suV6gaAq2ArN_-Uz8sU15dXkcDkbRFY3tFDRDFLZOqA26UaQ3NLdA9Z3nc69O4KYYfC6ZZjS4ZHAbtMSxJkZYxIkXesrQ9SU0MKUXsL9kE1BG62qkLdHWErkCqDD07X55Dli5Tuvj-Us6CzUmA-af3DqNKxqHPcF1EMysb3H9D_gABN8XC</recordid><startdate>20151101</startdate><enddate>20151101</enddate><creator>Caudal, D.</creator><creator>Alvarsson, A.</creator><creator>Björklund, A.</creator><creator>Svenningsson, P.</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>ADTPV</scope><scope>AOWAS</scope><scope>D95</scope></search><sort><creationdate>20151101</creationdate><title>Depressive-like phenotype induced by AAV-mediated overexpression of human α-synuclein in midbrain dopaminergic neurons</title><author>Caudal, D. ; Alvarsson, A. ; Björklund, A. ; Svenningsson, P.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c478t-7ff5294b66f1da16fc6d9403e1eb9365a3973ee3a630322a0461e28ec6ee55353</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Adrenocorticotropic Hormone - blood</topic><topic>Alpha-synuclein</topic><topic>alpha-Synuclein - genetics</topic><topic>alpha-Synuclein - metabolism</topic><topic>Animals</topic><topic>Anxiety</topic><topic>Basic Medicine</topic><topic>Corticosterone</topic><topic>Corticosterone - blood</topic><topic>Dependovirus - genetics</topic><topic>Depression</topic><topic>Depression - blood</topic><topic>Depression - etiology</topic><topic>Depression - genetics</topic><topic>Depression - pathology</topic><topic>Disease Models, Animal</topic><topic>Dopaminergic Neurons - pathology</topic><topic>Female</topic><topic>Food Preferences - psychology</topic><topic>Gene Expression Regulation - genetics</topic><topic>Humans</topic><topic>Longitudinal Studies</topic><topic>Maze Learning - physiology</topic><topic>Medical and Health Sciences</topic><topic>Medicin och hälsovetenskap</topic><topic>Medicinska och farmaceutiska grundvetenskaper</topic><topic>Mesencephalon - pathology</topic><topic>Neurosciences</topic><topic>Neurovetenskaper</topic><topic>Parkinson disease</topic><topic>Phenotype</topic><topic>Psychomotor Performance - physiology</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Rats, Transgenic</topic><topic>Stress, Psychological - complications</topic><topic>Swimming - psychology</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Caudal, D.</creatorcontrib><creatorcontrib>Alvarsson, A.</creatorcontrib><creatorcontrib>Björklund, A.</creatorcontrib><creatorcontrib>Svenningsson, P.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>SwePub</collection><collection>SwePub Articles</collection><collection>SWEPUB Lunds universitet</collection><jtitle>Experimental neurology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Caudal, D.</au><au>Alvarsson, A.</au><au>Björklund, A.</au><au>Svenningsson, P.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Depressive-like phenotype induced by AAV-mediated overexpression of human α-synuclein in midbrain dopaminergic neurons</atitle><jtitle>Experimental neurology</jtitle><addtitle>Exp Neurol</addtitle><date>2015-11-01</date><risdate>2015</risdate><volume>273</volume><spage>243</spage><epage>252</epage><pages>243-252</pages><issn>0014-4886</issn><eissn>1090-2430</eissn><abstract>Parkinson's disease (PD) is a neurodegenerative disorder characterized by a progressive loss of nigral dopaminergic neurons and by the presence of aggregates containing α-synuclein called Lewy bodies. Viral vector-induced overexpression of α-synuclein in dopaminergic neurons represents a model of PD which recapitulates disease progression better than commonly used neurotoxin models. Previous studies using this model have reported motor and cognitive impairments, whereas depression, mood and anxiety phenotypes are less described. To investigate these psychiatric phenotypes, Sprague–Dawley rats received bilateral injections of a recombinant adeno-associated virus (AAV) vector expressing human α-synuclein or GFP into the substantia nigra pars compacta. Behavior was assessed at two timepoints: 3 and 8weeks post-injection. We report that nigral α-synuclein overexpression led to a pronounced nigral dopaminergic cell loss accompanied by a smaller cell loss in the ventral tegmental area, and to a decreased striatal density of dopaminergic fibers. The AAV-α-synuclein group exhibited modest, but significant motor impairments 8weeks after vector administration. The AAV-α-synuclein group displayed depressive-like behavior in the forced swim test after 3weeks, and reduced sucrose preference at week 8. At both timepoints, overexpression of α-synuclein was linked to a hyperactive hypothalamic–pituitary–adrenal (HPA) axis regulation of corticosterone. The depressive-like phenotype was also correlated with decreased nigral brain-derived neurotrophic factor and spinophilin levels, and with decreased striatal levels of the activity-regulated cytoskeleton-associated protein. This study demonstrates that AAV-mediated α-synuclein overexpression in dopamine neurons is not only useful to model motor impairments of PD, but also depression. This study also provides evidence that depression in experimental Parkinsonism is correlated to dysregulation of the HPA axis and to alterations in proteins involved in synaptic plasticity.
•α-Synuclein overexpression in midbrain dopaminergic neurons induces a depressive-like phenotype•HPA axis hyperactivation is induced by α-synuclein overexpression in midbrain dopaminergic neurons•α-Synuclein overexpression is linked to decreased nigral BDNF and spinophilin levels, and decreased striatal Arc levels.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>26363495</pmid><doi>10.1016/j.expneurol.2015.09.002</doi><tpages>10</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0014-4886 |
ispartof | Experimental neurology, 2015-11, Vol.273, p.243-252 |
issn | 0014-4886 1090-2430 |
language | eng |
recordid | cdi_swepub_primary_oai_swepub_ki_se_510760 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Adrenocorticotropic Hormone - blood Alpha-synuclein alpha-Synuclein - genetics alpha-Synuclein - metabolism Animals Anxiety Basic Medicine Corticosterone Corticosterone - blood Dependovirus - genetics Depression Depression - blood Depression - etiology Depression - genetics Depression - pathology Disease Models, Animal Dopaminergic Neurons - pathology Female Food Preferences - psychology Gene Expression Regulation - genetics Humans Longitudinal Studies Maze Learning - physiology Medical and Health Sciences Medicin och hälsovetenskap Medicinska och farmaceutiska grundvetenskaper Mesencephalon - pathology Neurosciences Neurovetenskaper Parkinson disease Phenotype Psychomotor Performance - physiology Rats Rats, Sprague-Dawley Rats, Transgenic Stress, Psychological - complications Swimming - psychology Time Factors |
title | Depressive-like phenotype induced by AAV-mediated overexpression of human α-synuclein in midbrain dopaminergic neurons |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T07%3A28%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_swepu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Depressive-like%20phenotype%20induced%20by%20AAV-mediated%20overexpression%20of%20human%20%CE%B1-synuclein%20in%20midbrain%20dopaminergic%20neurons&rft.jtitle=Experimental%20neurology&rft.au=Caudal,%20D.&rft.date=2015-11-01&rft.volume=273&rft.spage=243&rft.epage=252&rft.pages=243-252&rft.issn=0014-4886&rft.eissn=1090-2430&rft_id=info:doi/10.1016/j.expneurol.2015.09.002&rft_dat=%3Cproquest_swepu%3E1733196331%3C/proquest_swepu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1733196331&rft_id=info:pmid/26363495&rft_els_id=S0014488615300844&rfr_iscdi=true |